a novel subcutaneous car-t therapy for the treatment of hematological malignancies
Published 2 years ago • 384 plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
1:38
the future of car-t for hematological malignancies and solid tumors
-
1:06
novel third-generation tlr2 co-stimulatory car-t cells for b-cell malignancies
-
2:48
an overview of the current landscape of car t-cell therapy in myeloma
-
3:33
an overview of the car t-cell therapy story
-
1:49
car-t cell approaches in cll: current progress & future directions
-
1:04:15
simplifying gmp car t and car nk cell therapy manufacturing processes [webinar]
-
1:01:36
deciphering car-t cells: exploring functional mechanisms to drive next generation immunotherapy
-
15:21
morphology of myeloid cells (part 1): neutrophilic sequence
-
1:39
the role of myeloid cells in car-t cell therapy
-
1:27
car t-cells in all: an overview
-
3:07
the role of bridging and timing in car-t
-
1:22
car t-cells in hemonc: where do we stand?
-
2:30
car-t as a new standard of care in lymphoma
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
4:10
car t-cell therapy for all
-
3:08
car t-cell therapy: the patient's perspective
-
1:55
developing the next generation of car-t cells
-
4:34
future perspectives in car-t therapy
-
0:37
hot topics in car t-cell therapy for all
-
2:44
do biomarkers exist for predicting response to car t-cell therapy?
-
2:30
the future of car t-cell therapy